{
  "id": "fda-medwatch",
  "fetchedAt": 1771776530494,
  "contentType": "application/rss+xml; charset=utf-8",
  "body": "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n<rss xmlns:dc=\"http://purl.org/dc/elements/1.1/\" version=\"2.0\" xml:base=\"http://www.fda.gov/\">\n  <channel>\n    <title>MedWatch Safety Alerts RSS Feed</title>\n    <link>http://www.fda.gov/</link>\n    <description/>\n    <language>en</language>\n    \n    <item>\n  <title>Early Alert: Trividia Health Issues Correction for TRUE METRIX Blood Glucose Monitoring Systems  </title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-trividia-health-issues-correction-true-metrix-blood-glucose-monitoring-systems</link>\n  <description>Trividia recommends that device users who receive an E-5 error code and are experiencing symptoms of high glucose should seek medical care immediately   </description>\n  <pubDate>Tue, 17 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-trividia-health-issues-correction-true-metrix-blood-glucose-monitoring-systems</guid>\n    </item>\n<item>\n  <title>Electronic Homecare Bed Correction: Medline Updates Use Instructions for Homecare Beds</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/electronic-homecare-bed-correction-medline-updates-use-instructions-homecare-beds</link>\n  <description>Medline updates use instructions for Electronic Homecare Beds due to risk of electrical fires and entrapment.</description>\n  <pubDate>Fri, 13 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/electronic-homecare-bed-correction-medline-updates-use-instructions-homecare-beds</guid>\n    </item>\n<item>\n  <title>Emergency Response Safety Kit Recall: Airlife Removes Certain Broselow Pediatric Emergency Rainbow Tapes and Broselow ALS Organizers</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/emergency-response-safety-kit-recall-airlife-removes-certain-broselow-pediatric-emergency-rainbow</link>\n  <description>AirLife is removing Broselow Rainbow Tapes due to incorrectly printed medication dosing information. </description>\n  <pubDate>Wed, 11 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/emergency-response-safety-kit-recall-airlife-removes-certain-broselow-pediatric-emergency-rainbow</guid>\n    </item>\n<item>\n  <title>Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems </title>\n  <link>http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/trividia-health-inc-initiates-labeling-correction-all-true-metrixr-blood-glucose-monitoring-systems</link>\n  <description>FT. LAUDERDALE, FL) – February 6, 2026 – Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monit</description>\n  <pubDate>Fri, 06 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/trividia-health-inc-initiates-labeling-correction-all-true-metrixr-blood-glucose-monitoring-systems</guid>\n    </item>\n<item>\n  <title>Detachable Coil System Recall: J&amp;J MedTech/CERENOVUS Inc. Remove CEREPAK Detachable Coil System</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/detachable-coil-system-recall-jj-medtechcerenovus-inc-remove-cerepak-detachable-coil-system</link>\n  <description>MedTech/CERENOVUS is removing CEREPAK Detachable Coil Systems due to a higher than expected failure to detach rate</description>\n  <pubDate>Thu, 05 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/detachable-coil-system-recall-jj-medtechcerenovus-inc-remove-cerepak-detachable-coil-system</guid>\n    </item>\n<item>\n  <title>Glucose Monitor Sensor Recall: Abbott Diabetes Care Removes Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/glucose-monitor-sensor-recall-abbott-diabetes-care-removes-certain-freestyle-libre-3-and-freestyle</link>\n  <description>Certain Abbott Diabetes Care Continuous Glucose Monitor sensors may incorrect or lower than actual glucose readings</description>\n  <pubDate>Thu, 05 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/glucose-monitor-sensor-recall-abbott-diabetes-care-removes-certain-freestyle-libre-3-and-freestyle</guid>\n    </item>\n<item>\n  <title>Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication</title>\n  <link>http://www.fda.gov/medical-devices/safety-communications/risk-false-positive-lead-test-results-certain-capillary-blood-collection-tubes-used-magellan</link>\n  <description>FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.</description>\n  <pubDate>Tue, 03 Feb 2026 12:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/safety-communications/risk-false-positive-lead-test-results-certain-capillary-blood-collection-tubes-used-magellan</guid>\n    </item>\n<item>\n  <title>Early Alert: Heart Pump Issue from Abiomed</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-heart-pump-issue-abiomed</link>\n  <description>The differential pressure sensor in certain Impella devices may malfunction and cause sensor values to drift. </description>\n  <pubDate>Tue, 03 Feb 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-heart-pump-issue-abiomed</guid>\n    </item>\n<item>\n  <title>Early Alert: Insufflation Unit Issue from Olympus</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-insufflation-unit-issue-olympus</link>\n  <description>Olympus is removing certain High Flow Insufflation Unit models due to software issues that may lead to overpressure events.</description>\n  <pubDate>Thu, 22 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-insufflation-unit-issue-olympus</guid>\n    </item>\n<item>\n  <title>Early Alert: Wound and Burn Dressing Issue from Integra LifeSciences</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-wound-and-burn-dressing-issue-integra-lifesciences</link>\n  <description>Integra is removing all MediHoney Wound and Burn products and certain lots of CVS Wound Gel that may have breached sterile barriers</description>\n  <pubDate>Thu, 22 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-wound-and-burn-dressing-issue-integra-lifesciences</guid>\n    </item>\n<item>\n  <title>Anesthesia Kit Recall: Medline Removes Anesthesia Circuits and Anesthesia Circuit Kits</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthesia-kit-recall-medline-removes-anesthesia-circuits-and-anesthesia-circuit-kits</link>\n  <description>Medline is removing certain anesthesia circuit kits due to cracks and leaks in the tubing.</description>\n  <pubDate>Fri, 16 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthesia-kit-recall-medline-removes-anesthesia-circuits-and-anesthesia-circuit-kits</guid>\n    </item>\n<item>\n  <title>Olympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles</title>\n  <link>http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/olympus-expands-voluntary-recall-vizishot-2-flex-19g-ebus-tbna-needles</link>\n  <description>CENTER VALLEY, Pa., (January 16, 2026)  — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching during</description>\n  <pubDate>Fri, 16 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/olympus-expands-voluntary-recall-vizishot-2-flex-19g-ebus-tbna-needles</guid>\n    </item>\n<item>\n  <title>Early Alert: Stent and Electrocautery-Enhanced Delivery System Issue from Boston Scientific</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-stent-and-electrocautery-enhanced-delivery-system-issue-boston-scientific</link>\n  <description>Boston Scientific is removing certain stents and delivery systems due to issues with deployment and expansion.</description>\n  <pubDate>Fri, 16 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-stent-and-electrocautery-enhanced-delivery-system-issue-boston-scientific</guid>\n    </item>\n<item>\n  <title>Anesthetic Vaporizer Recall: Draeger Removes Vapor 2000 and Vapor 3000 Vaporizers </title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthetic-vaporizer-recall-draeger-removes-vapor-2000-and-vapor-3000-vaporizers</link>\n  <description>Draeger is removing certain Vapor 2000 and Vapor 3000 Vaporizers due to impurities found within a component.</description>\n  <pubDate>Fri, 16 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/anesthetic-vaporizer-recall-draeger-removes-vapor-2000-and-vapor-3000-vaporizers</guid>\n    </item>\n<item>\n  <title>Abbott Initiates Medical Device Correction for Certain  FreeStyle Libre® 3 and FreeStyle Libre 3 Plus Sensors in the U.S. </title>\n  <link>http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-initiates-medical-device-correction-certain-freestyle-librer-3-and-freestyle-libre-3-plus</link>\n  <description>ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some sensors may provide incorrect low glucose readings.  </description>\n  <pubDate>Thu, 15 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-initiates-medical-device-correction-certain-freestyle-librer-3-and-freestyle-libre-3-plus</guid>\n    </item>\n<item>\n  <title>Early Alert: Dialysis Tubing Set Issue from Vantive</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-dialysis-tubing-set-issue-vantive</link>\n  <description>Prismaflex Set deaeration chambers may dislodge from the Prismaflex Control Unit during use. </description>\n  <pubDate>Wed, 14 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-dialysis-tubing-set-issue-vantive</guid>\n    </item>\n<item>\n  <title>Organ Recovery Pack Correction: AVID Medical Issues Correction for Medical Convenience and Organ Recovery Kits</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/organ-recovery-pack-correction-avid-medical-issues-correction-medical-convenience-and-organ-recovery</link>\n  <description>AVID is removing bags from Organ Recovery and Medical Convenience Kits due to the bags being made of non-medical grade Poly and lacking intact seals.</description>\n  <pubDate>Fri, 09 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/organ-recovery-pack-correction-avid-medical-issues-correction-medical-convenience-and-organ-recovery</guid>\n    </item>\n<item>\n  <title>Anthony Trinh, 123Herbals LLC (123HERBALS.COM) Issues Nationwide Recall of Silintan Capsules Due to the Presence of Undeclared Meloxicam</title>\n  <link>http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/anthony-trinh-123herbals-llc-123herbalscom-issues-nationwide-recall-silintan-capsules-due-presence</link>\n  <description>Rosemead, CA, ANTHONY TRINH, 123herbals LLC is voluntarily recalling all lots of Silintan capsules to the consumer level. FDA analysis has found the product to be tainted with meloxicam. Meloxicam, is an approved Nonsteroidal Anti-Inflammatory Drug, (NSAID) indicated for management of osteoarthritis</description>\n  <pubDate>Fri, 09 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/anthony-trinh-123herbals-llc-123herbalscom-issues-nationwide-recall-silintan-capsules-due-presence</guid>\n    </item>\n<item>\n  <title>Modern Warrior Recalls “Modern Warrior Ready” Dietary Supplement Due to Undeclared 1,4-DMAA and Aniracetam, as Well as Tianeptine, Which has Not Been Approved for Supplement Use by the FDA.</title>\n  <link>http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/modern-warrior-recalls-modern-warrior-ready-dietary-supplement-due-undeclared-14-dmaa-and-aniracetam</link>\n  <description>[Phoenix, Arizona] – [12/22/25] – Modern Warrior is voluntarily recalling all lots of Modern Warrior Ready, a dietary supplement sold directly to consumers, after regulatory  testing identified the presence of undeclared ingredients, including tianeptine, 1,4-DMAA, and aniracetam..Tianeptine can c</description>\n  <pubDate>Fri, 09 Jan 2026 00:00:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/modern-warrior-recalls-modern-warrior-ready-dietary-supplement-due-undeclared-14-dmaa-and-aniracetam</guid>\n    </item>\n<item>\n  <title>Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters</title>\n  <link>http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/intravascular-picc-catheter-recall-bard-removes-powerpicc-intravascular-catheters</link>\n  <description>This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program</description>\n  <pubDate>Mon, 05 Jan 2026 12:52:00 EST</pubDate>\n    <dc:creator>FDA</dc:creator>\n    <guid isPermaLink=\"true\">http://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/intravascular-picc-catheter-recall-bard-removes-powerpicc-intravascular-catheters</guid>\n    </item>\n\n  </channel>\n</rss>\n",
  "httpStatus": 200
}